Jul 2, 2020 08:55AM
Jul 2, 2020 08:45AM
May 14, 2020 08:00AM
May 11, 2020 08:00AM
May 5, 2020 09:11AM
May 5, 2020 07:02AM
May 5, 2020 07:00AM Alexion to Acquire Portola
Mar 16, 2020 08:06AM
Mar 16, 2020 08:05AM
Mar 5, 2020 08:30AM
Feb 3, 2020 08:38AM
Feb 3, 2020 08:30AM
Jan 9, 2020 04:13PM
Jan 9, 2020 04:01PM Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million
Dec 9, 2019 03:22PM
Dec 9, 2019 03:21PM
Dec 9, 2019 06:19AM
Dec 8, 2019 12:00PM
Nov 15, 2019 04:29PM
Nov 15, 2019 04:25PM
Nov 6, 2019 10:07AM Portola Pharmaceuticals to Present Multiple Abstracts at the 61st American Society of Hematology (ASH) Annual Meeting
Oct 28, 2019 09:08AM
Oct 28, 2019 09:00AM
Aug 8, 2019 08:58AM
Aug 6, 2019 08:30AM
Aug 5, 2019 07:05AM
Aug 5, 2019 07:00AM
Jul 8, 2019 08:37AM Portola Pharma (PTLA) Reports New In Vitro Data at ISTH 2019 Meeting
Jul 8, 2019 08:30AM
Jun 19, 2019 11:06AM
Jun 19, 2019 11:05AM
May 22, 2019 10:45AM
May 8, 2019 08:01AM
Apr 26, 2019 02:01PM
Apr 26, 2019 02:00PM European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals’ Ondexxya™ (andexanet alfa), the First and Only Antidote for the Reversal of Factor Xa Inhibitors
Apr 26, 2019 02:00PM
Apr 24, 2019 08:30AM
Apr 17, 2019 04:15PM
Mar 20, 2019 05:07PM
Mar 20, 2019 05:00PM
Mar 6, 2019 04:10PM
Mar 1, 2019 08:08AM Portola Pharma (PTLA) Enters into $125 Million Loan Agreement with HealthCare Royalty Partners and Athyrium Capital Management
Mar 1, 2019 08:05AM
Mar 1, 2019 08:03AM
Mar 1, 2019 07:39AM
Mar 1, 2019 07:38AM
Feb 7, 2019 04:03PM
Feb 1, 2019 08:30AM
Jan 30, 2019 08:43AM Portola Pharmaceuticals to Present Full Results from the ANNEXA-4 Study of Andexxa During a Late-Breaking Oral Presentation at the International Stroke Conference 2019
Jan 28, 2019 09:23AM

322,312 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All